Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of Aug. 3-7:
GI & Endoscopy
With the dog days of summer in the rear view, gastroenterology has had a specialty-changing year severely affected by the COVID-19 pandemic, but the specialty is gradually recovering and moving forward. Here are seven trends that will shape the specialty…
Exact Sciences reported $268.9 million in revenue for the second quarter ended June 30, but still had a net loss of $86.1 million.
A new white paper from the American Gastroenterological Association calls for better risk assessment, more noninvasive testing options and targeted colonoscopy referrals to reduce colorectal cancer fatalities.
The FirstSightCRC blood-based multimodal colorectal cancer test could be inching its way closer to market, OncLive reports.
Here are six updates from gastroenterology companies and practices from the past week:
Gastroenterology has seen several partnerships arise since March 11, when the World Health Organization officially declared a pandemic.
Physician assistants can perform colonoscopies as accurately as gastroenterologists in average-risk patients, according to a study published in the Journal of the American Academy of Physician Assistants, reported on by Clinical Advisor.
CRH Medical Corp. acquired a majority interest in Orange County Anesthesia Associates, effective Aug. 3.
A July study published in Gut underscores the urgent need to head off "an impending cancer healthcare crisis," Medscape reports.
